{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:04:04Z","timestamp":1794953044998,"version":"4.9.1"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-026-01747-y","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T09:02:22Z","timestamp":1785315742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["In vivo CRISPR base editing for treatment of Huntington\u2019s disease"],"prefix":"10.1038","author":[{"given":"Shraddha","family":"Shirguppe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gapinske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devyani","family":"Swami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyrollos","family":"Shenouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Miskalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6558-0307","authenticated-orcid":false,"given":"Nicholas","family":"Gosstola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7884-3958","authenticated-orcid":false,"given":"Daniela","family":"Del Bosque Siller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Joulani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddie G.","family":"Szkwarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananthan","family":"Nambiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anagha S.","family":"Dangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah","family":"Odle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle E.","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianna","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Stilger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy S.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphine","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin K. W.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3701-492X","authenticated-orcid":false,"given":"Sergei","family":"Maslov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6004-9664","authenticated-orcid":false,"given":"Thomas","family":"Gaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9167-0004","authenticated-orcid":false,"given":"Pablo","family":"Perez-Pinera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"1747_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates, G. P. et al. Huntington disease. Nat. Rev. Dis. Primers 1, 15005 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1747_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1097-2765(02)00602-0","volume":"10","author":"A Lunkes","year":"2002","unstructured":"Lunkes, A. et al. Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Mol. Cell 10, 259\u2013269 (2002).","journal-title":"Mol. Cell"},{"key":"1747_CR3","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1093\/hmg\/ddn175","volume":"17","author":"CE Wang","year":"2008","unstructured":"Wang, C. E. et al. Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington\u2019s disease. Hum. Mol. Genet. 17, 2738\u20132751 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"1747_CR4","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1073\/pnas.1221891110","volume":"110","author":"K Sathasivam","year":"2013","unstructured":"Sathasivam, K. et al. Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc. Natl Acad. Sci. USA 110, 2366\u20132370 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1747_CR5","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1093\/brain\/awac241","volume":"145","author":"S Fienko","year":"2022","unstructured":"Fienko, S. et al. Alternative processing of human HTT mRNA with implications for Huntington\u2019s disease therapeutics. Brain 145, 4409\u20134424 (2022).","journal-title":"Brain"},{"key":"1747_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.tins.2011.09.001","volume":"34","author":"RK Graham","year":"2011","unstructured":"Graham, R. K., Ehrnhoefer, D. E. & Hayden, M. R. Caspase-6 and neurodegeneration. Trends Neurosci. 34, 646\u2013656 (2011).","journal-title":"Trends Neurosci."},{"key":"1747_CR7","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.chembiol.2019.07.001","volume":"26","author":"DE Ehrnhoefer","year":"2019","unstructured":"Ehrnhoefer, D. E. et al. Activation of caspase-6 is promoted by a mutant huntingtin fragment and blocked by an allosteric inhibitor compound. Cell Chem. Biol. 26, 1295\u20131305.e6 (2019).","journal-title":"Cell Chem. Biol."},{"key":"1747_CR8","doi-asserted-by":"publisher","first-page":"19831","DOI":"10.1074\/jbc.M001475200","volume":"275","author":"CL Wellington","year":"2000","unstructured":"Wellington, C. L. et al. Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J. Biol. Chem. 275, 19831\u201319838 (2000).","journal-title":"J. Biol. Chem."},{"key":"1747_CR9","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","volume":"125","author":"RK Graham","year":"2006","unstructured":"Graham, R. K. et al. Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125, 1179\u20131191 (2006).","journal-title":"Cell"},{"key":"1747_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1089\/nat.2013.0452","volume":"24","author":"MM Evers","year":"2014","unstructured":"Evers, M. M. et al. Preventing formation of toxic N-terminal huntingtin fragments through antisense oligonucleotide-mediated protein modification. Nucleic Acid Ther. 24, 4\u201312 (2014).","journal-title":"Nucleic Acid Ther."},{"key":"1747_CR11","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420\u2013424 (2016).","journal-title":"Nature"},{"key":"1747_CR12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M. et al. Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature 551, 464\u2013471 (2017).","journal-title":"Nature"},{"key":"1747_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1482-5","volume":"19","author":"M Gapinske","year":"2018","unstructured":"Gapinske, M. et al. CRISPR-SKIP: programmable gene splicing with single base editors. Genome Biol. 19, 107 (2018).","journal-title":"Genome Biol."},{"key":"1747_CR14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.molcel.2018.09.002","volume":"72","author":"J Yuan","year":"2018","unstructured":"Yuan, J. et al. Genetic modulation of RNA splicing with a CRISPR-guided cytidine deaminase. Mol. Cell 72, 380\u2013394.e7 (2018).","journal-title":"Mol. Cell"},{"key":"1747_CR15","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1096\/fj.201701510RRR","volume":"33","author":"DDO Martin","year":"2019","unstructured":"Martin, D. D. O., Schmidt, M. E., Nguyen, Y. T., Lazic, N. & Hayden, M. R. Identification of a novel caspase cleavage site in huntingtin that regulates mutant huntingtin clearance. FASEB J. 33, 3190\u20133197 (2019).","journal-title":"FASEB J."},{"key":"1747_CR16","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1093\/nar\/gkg616","volume":"31","author":"L Cartegni","year":"2003","unstructured":"Cartegni, L. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res. 31, 3568\u20133571 (2003).","journal-title":"Nucleic Acids Res."},{"key":"1747_CR17","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1093\/nar\/gkp215","volume":"37","author":"F-O Desmet","year":"2009","unstructured":"Desmet, F.-O. et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 37, e67 (2009).","journal-title":"Nucleic Acids Res."},{"key":"1747_CR18","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nature09886","volume":"471","author":"E Deltcheva","year":"2011","unstructured":"Deltcheva, E. et al. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471, 602\u2013607 (2011).","journal-title":"Nature"},{"key":"1747_CR19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"PD Hsu","year":"2013","unstructured":"Hsu, P. D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827\u2013832 (2013).","journal-title":"Nat. Biotechnol."},{"key":"1747_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature26155","volume":"556","author":"JH Hu","year":"2018","unstructured":"Hu, J. H. et al. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature 556, 57\u201363 (2018).","journal-title":"Nature"},{"key":"1747_CR21","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/nbt.3404","volume":"33","author":"BP Kleinstiver","year":"2015","unstructured":"Kleinstiver, B. P. et al. Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. Nat. Biotechnol. 33, 1293\u20131298 (2015).","journal-title":"Nat. Biotechnol."},{"key":"1747_CR22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/mt.2015.151","volume":"24","author":"T Gaj","year":"2016","unstructured":"Gaj, T., Epstein, B. E. & Schaffer, D. V. Genome engineering using adeno-associated virus: basic and clinical research applications. Mol. Ther. 24, 458\u2013464 (2016).","journal-title":"Mol. Ther."},{"key":"1747_CR23","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.ymthe.2020.01.005","volume":"28","author":"CKW Lim","year":"2020","unstructured":"Lim, C. K. W. et al. Treatment of a mouse model of ALS by in vivo base editing. Mol. Ther. 28, 1177\u20131189 (2020).","journal-title":"Mol. Ther."},{"key":"1747_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","volume":"4","author":"JM Levy","year":"2020","unstructured":"Levy, J. M. et al. Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses. Nat. Biomed. Eng. 4, 97\u2013110 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"1747_CR25","doi-asserted-by":"publisher","first-page":"108349","DOI":"10.1016\/j.biotechadv.2024.108349","volume":"73","author":"S Anastassov","year":"2024","unstructured":"Anastassov, S., Filo, M. & Khammash, M. Inteins: a Swiss army knife for synthetic biology. Biotechnol. Adv. 73, 108349 (2024). 07\/01.","journal-title":"Biotechnol. Adv."},{"key":"1747_CR26","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.omtn.2023.07.029","volume":"33","author":"M Gapinske","year":"2023","unstructured":"Gapinske, M. et al. Targeting Duchenne muscular dystrophy by skipping DMD exon 45 with base editors. Mol. Ther. Nucleic Acids 33, 572\u2013586 (2023).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1747_CR27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan, K. et al. Predicting splicing from primary sequence with deep learning. Cell 176, 535\u2013548.e24 (2019).","journal-title":"Cell"},{"key":"1747_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/1066527041410418","volume":"11","author":"G Yeo","year":"2004","unstructured":"Yeo, G. & Burge, C. B. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol. 11, 377\u2013394 (2004).","journal-title":"J. Comput. Biol."},{"key":"1747_CR29","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","volume":"30","author":"S Bae","year":"2014","unstructured":"Bae, S., Park, J. & Kim, J.-S. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30, 1473\u20131475 (2014).","journal-title":"Bioinformatics"},{"key":"1747_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55202-x","volume":"9","author":"H Aviolat","year":"2019","unstructured":"Aviolat, H. et al. Assessing average somatic CAG repeat instability at the protein level. Sci. Rep. 9, 19152 (2019).","journal-title":"Sci. Rep."},{"key":"1747_CR31","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1093\/hmg\/ddi407","volume":"14","author":"JM Van Raamsdonk","year":"2005","unstructured":"Van Raamsdonk, J. M., Murphy, Z., Slow, E. J., Leavitt, B. R. & Hayden, M. R. Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease. Hum. Mol. Genet. 14, 3823\u20133835 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"1747_CR32","doi-asserted-by":"publisher","first-page":"9928","DOI":"10.1523\/JNEUROSCI.2185-07.2007","volume":"27","author":"CN Cearley","year":"2007","unstructured":"Cearley, C. N. & Wolfe, J. H. A single injection of an adeno-associated virus vector into nuclei with divergent connections results in widespread vector distribution in the brain and global correction of a neurogenetic disease. J. Neurosci. 27, 9928\u20139940 (2007).","journal-title":"J. Neurosci."},{"key":"1747_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nbt.1515","volume":"27","author":"KD Foust","year":"2009","unstructured":"Foust, K. D. et al. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat. Biotechnol. 27, 59\u201365 (2009).","journal-title":"Nat. Biotechnol."},{"key":"1747_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3233\/JHD-180302","volume":"7","author":"E Mondo","year":"2018","unstructured":"Mondo, E. et al. Selective neuronal uptake and distribution of AAVrh8, AAV9, and AAVrh10 in sheep after intra-striatal administration. J. Huntingtons Dis. 7, 309\u2013319 (2018).","journal-title":"J. Huntingtons Dis."},{"key":"1747_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/5007","volume":"21","author":"P Soriano","year":"1999","unstructured":"Soriano, P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21, 70\u201371 (1999).","journal-title":"Nat. Genet."},{"key":"1747_CR36","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1083\/jcb.200909067","volume":"187","author":"LM Thompson","year":"2009","unstructured":"Thompson, L. M. et al. IKK phosphorylates huntingtin and targets it for degradation by the proteasome and lysosome. J. Cell Biol. 187, 1083\u20131099 (2009).","journal-title":"J. Cell Biol."},{"key":"1747_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26684-z","volume":"12","author":"N Riguet","year":"2021","unstructured":"Riguet, N. et al. Nuclear and cytoplasmic huntingtin inclusions exhibit distinct biochemical composition, interactome and ultrastructural properties. Nat. Commun. 12, 6579 (2021).","journal-title":"Nat. Commun."},{"key":"1747_CR38","doi-asserted-by":"publisher","first-page":"e0123527","DOI":"10.1371\/journal.pone.0123527","volume":"10","author":"N Carty","year":"2015","unstructured":"Carty, N. et al. Characterization of HTT inclusion size, location, and timing in the zQ175 mouse model of Huntington\u2019s disease: an in vivo high-content imaging study. PLoS ONE 10, e0123527 (2015).","journal-title":"PLoS ONE"},{"key":"1747_CR39","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow, E. J. et al. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum. Mol. Genet. 12, 1555\u20131567 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"1747_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-015-2251-4","volume":"16","author":"Z Bayram-Weston","year":"2015","unstructured":"Bayram-Weston, Z. et al. Similar striatal gene expression profiles in the striatum of the YAC128 and HdhQ150 mouse models of Huntington\u2019s disease are not reflected in mutant Huntingtin inclusion prevalence. BMC Genomics 16, 1079 (2015).","journal-title":"BMC Genomics"},{"key":"1747_CR41","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nn.3691","volume":"17","author":"X Tong","year":"2014","unstructured":"Tong, X. et al. Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington\u2019s disease model mice. Nat. Neurosci. 17, 694\u2013703 (2014).","journal-title":"Nat. Neurosci."},{"key":"1747_CR42","doi-asserted-by":"publisher","first-page":"621.e617","DOI":"10.1016\/j.neurobiolaging.2011.02.015","volume":"33","author":"AD Kraft","year":"2012","unstructured":"Kraft, A. D., Kaltenbach, L. S., Lo, D. C. & Harry, G. J. Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons. Neurobiol. Aging 33, 621.e617\u2013633 (2012).","journal-title":"Neurobiol. Aging"},{"key":"1747_CR43","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nbt.4172","volume":"36","author":"LW Koblan","year":"2018","unstructured":"Koblan, L. W. et al. Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat. Biotechnol. 36, 843\u2013846 (2018).","journal-title":"Nat. Biotechnol."},{"key":"1747_CR44","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","volume":"38","author":"MF Richter","year":"2020","unstructured":"Richter, M. F. et al. Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity. Nat. Biotechnol. 38, 883\u2013891 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1747_CR45","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.aba8853","volume":"368","author":"RT Walton","year":"2020","unstructured":"Walton, R. T., Christie, K. A., Whittaker, M. N. & Kleinstiver, B. P. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants. Science 368, 290\u2013296 (2020).","journal-title":"Science"},{"key":"1747_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41421-019-0109-7","volume":"5","author":"J Winter","year":"2019","unstructured":"Winter, J. et al. Targeted exon skipping with AAV-mediated split adenine base editors. Cell Discov. 5, 41 (2019).","journal-title":"Cell Discov."},{"key":"1747_CR47","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1038\/mtna.2014.64","volume":"3","author":"TJ Cradick","year":"2014","unstructured":"Cradick, T. J., Qiu, P., Lee, C. M., Fine, E. J. & Bao, G. COSMID: a web-based tool for identifying and validating CRISPR\/Cas off-target sites. Mol. Ther. Nucleic Acids 3, e214 (2014).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1747_CR48","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1242\/jcs.057075","volume":"122","author":"C Ostlund","year":"2009","unstructured":"Ostlund, C. et al. Dynamics and molecular interactions of linker of nucleoskeleton and cytoskeleton (LINC) complex proteins. J. Cell Sci. 122, 4099\u20134108 (2009).","journal-title":"J. Cell Sci."},{"key":"1747_CR49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","volume":"101","author":"A Yamamoto","year":"2000","unstructured":"Yamamoto, A., Lucas, J. J. & Hen, R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease. Cell 101, 57\u201366 (2000).","journal-title":"Cell"},{"key":"1747_CR50","doi-asserted-by":"publisher","first-page":"9773","DOI":"10.1523\/JNEUROSCI.3183-05.2005","volume":"25","author":"M Di\u0301az-Herna\u0301ndez","year":"2005","unstructured":"Di\u0301az-Herna\u0301ndez, M. et al. Full motor recovery despite striatal neuron loss and formation of irreversible amyloid-like inclusions in a conditional mouse model of Huntington\u2019s disease. J. Neurosci. 25, 9773\u20139781 (2005).","journal-title":"J. Neurosci."},{"key":"1747_CR51","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","volume":"74","author":"HB Kordasiewicz","year":"2012","unstructured":"Kordasiewicz, H. B. et al. Sustained therapeutic reversal of Huntington\u2019s disease by transient repression of huntingtin synthesis. Neuron 74, 1031\u20131044 (2012).","journal-title":"Neuron"},{"key":"1747_CR52","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1073\/pnas.0501507102","volume":"102","author":"SQ Harper","year":"2005","unstructured":"Harper, S. Q. et al. RNA interference improves motor and neuropathological abnormalities in a Huntington\u2019s disease mouse model. Proc. Natl Acad. Sci. USA 102, 5820\u20135825 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1747_CR53","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","volume":"12","author":"E Rodriguez-Lebron","year":"2005","unstructured":"Rodriguez-Lebron, E., Denovan-Wright, E. M., Nash, K., Lewin, A. S. & Mandel, R. J. Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington\u2019s disease transgenic mice. Mol. Ther. 12, 618\u2013633 (2005).","journal-title":"Mol. Ther."},{"key":"1747_CR54","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/mt.2011.201","volume":"19","author":"JB Carroll","year":"2011","unstructured":"Carroll, J. B. et al. Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene \/ allele-specific silencing of mutant huntingtin. Mol. Ther. 19, 2178\u20132185 (2011).","journal-title":"Mol. Ther."},{"key":"1747_CR55","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1038\/mt.2014.153","volume":"22","author":"AL Southwell","year":"2014","unstructured":"Southwell, A. L. et al. In vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotides. Mol. Ther. 22, 2093\u20132106 (2014).","journal-title":"Mol. Ther."},{"key":"1747_CR56","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.nbd.2017.12.015","volume":"111","author":"I Dragatsis","year":"2018","unstructured":"Dragatsis, I. et al. Effect of early embryonic deletion of huntingtin from pyramidal neurons on the development and long-term survival of neurons in cerebral cortex and striatum. Neurobiol. Dis. 111, 102\u2013117 (2018).","journal-title":"Neurobiol. Dis."},{"key":"1747_CR57","doi-asserted-by":"publisher","first-page":"e1006846","DOI":"10.1371\/journal.pgen.1006846","volume":"13","author":"T Vogt","year":"2017","unstructured":"Vogt, T., Dietrich, P., Johnson, I. M., Alli, S. & Dragatsis, I. Elimination of huntingtin in the adult mouse leads to progressive behavioral deficits, bilateral thalamic calcification, and altered brain iron homeostasis. PLoS Genet. 13, e1006846 (2017).","journal-title":"PLoS Genet."},{"key":"1747_CR58","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ymthe.2016.11.010","volume":"25","author":"AM Monteys","year":"2017","unstructured":"Monteys, A. M., Ebanks, S. A., Keiser, M. S. & Davidson, B. L. CRISPR\/Cas9 editing of the mutant huntingtin allele in vitro and in vivo. Mol. Ther. 25, 12\u201323 (2017).","journal-title":"Mol. Ther."},{"key":"1747_CR59","first-page":"4566","volume":"25","author":"JW Shin","year":"2016","unstructured":"Shin, J. W. et al. Permanent inactivation of Huntington\u2019s disease mutation by personalized allele-specific CRISPR\/Cas9. Hum. Mol. Genet. 25, 4566\u20134576 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"1747_CR60","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/hum.2020.323","volume":"33","author":"SR Oikemus","year":"2022","unstructured":"Oikemus, S. R. et al. Allele-specific knockdown of mutant huntingtin protein via editing at coding region single nucleotide polymorphism heterozygosities. Hum. Gene Ther. 33, 25\u201336 (2022).","journal-title":"Hum. Gene Ther."},{"key":"1747_CR61","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature04791","volume":"441","author":"D Grimm","year":"2006","unstructured":"Grimm, D. et al. Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways. Nature 441, 537\u2013541 (2006).","journal-title":"Nature"},{"key":"1747_CR62","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.omtn.2019.07.009","volume":"17","author":"FK Ekman","year":"2019","unstructured":"Ekman, F. K. et al. CRISPR-Cas9-mediated genome editing increases lifespan and improves motor deficits in a Huntington\u2019s disease mouse model. Mol. Ther. Nucleic Acids 17, 829\u2013839 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1747_CR63","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1172\/JCI92087","volume":"127","author":"S Yang","year":"2017","unstructured":"Yang, S. et al. CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington\u2019s disease. J. Clin. Invest. 127, 2719\u20132724 (2017).","journal-title":"J. Clin. Invest."},{"key":"1747_CR64","doi-asserted-by":"publisher","unstructured":"Tan, K. et al. Treatment of Huntington\u2019s disease with a pan-HTT-targeting CRISPR nuclease. Mol. Ther. https:\/\/doi.org\/10.1016\/j.ymthe.2026.04.038 (2026).","DOI":"10.1016\/j.ymthe.2026.04.038"},{"key":"1747_CR65","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","volume":"578","author":"JA Doudna","year":"2020","unstructured":"Doudna, J. A. The promise and challenge of therapeutic genome editing. Nature 578, 229\u2013236 (2020).","journal-title":"Nature"},{"key":"1747_CR66","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.4192","volume":"36","author":"M Kosicki","year":"2018","unstructured":"Kosicki, M., Tomberg, K. & Bradley, A. Repair of double-strand breaks induced by CRISPR\u2013Cas9 leads to large deletions and complex rearrangements. Nat. Biotechnol. 36, 765\u2013771 (2018).","journal-title":"Nat. Biotechnol."},{"key":"1747_CR67","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/mt.2009.17","volume":"17","author":"RL Boudreau","year":"2009","unstructured":"Boudreau, R. L. et al. Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington\u2019s disease mice. Mol. Ther. 17, 1053\u20131063 (2009).","journal-title":"Mol. Ther."},{"key":"1747_CR68","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/s41588-025-02172-8","volume":"57","author":"Z Matuszek","year":"2025","unstructured":"Matuszek, Z. et al. Base editing of trinucleotide repeats that cause Huntington\u2019s disease and Friedreich\u2019s ataxia reduces somatic repeat expansions in patient cells and in mice. Nat. Genet. 57, 1437\u20131451 (2025).","journal-title":"Nat. Genet."},{"key":"1747_CR69","doi-asserted-by":"publisher","first-page":"RP89782","DOI":"10.7554\/eLife.89782.2","volume":"12","author":"DE Choi","year":"2024","unstructured":"Choi, D. E. et al. Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington\u2019s disease. Elife 12, RP89782 (2024).","journal-title":"Elife"},{"key":"1747_CR70","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s42003-021-02304-w","volume":"4","author":"S Oura","year":"2021","unstructured":"Oura, S. et al. Precise CAG repeat contraction in a Huntington\u2019s disease mouse model is enabled by gene editing with SpCas9-NG. Commun. Biol. 4, 771 (2021).","journal-title":"Commun. Biol."},{"key":"1747_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-024-02079-6","volume":"22","author":"P Sledzinski","year":"2024","unstructured":"Sledzinski, P., Nowaczyk, M., Smielowska, M. I. & Olejniczak, M. CRISPR\/Cas9-induced double-strand breaks in the huntingtin locus lead to CAG repeat contraction through DNA end resection and homology-mediated repair. BMC Biol. 22, 282 (2024).","journal-title":"BMC Biol."},{"key":"1747_CR72","doi-asserted-by":"crossref","unstructured":"Landles, C., Weiss, A., Franklin, S., Howland, D. & Bates, G. Caspase-6 does not contribute to the proteolysis of mutant huntingtin in the HdhQ150 knock-in mouse model of Huntington\u2019s disease. PLoS Curr. 4, e4fd085bfc9973 (2012).","DOI":"10.1371\/4fd085bfc9973"},{"key":"1747_CR73","doi-asserted-by":"publisher","first-page":"7454","DOI":"10.1523\/JNEUROSCI.6379-11.2012","volume":"32","author":"J Gafni","year":"2012","unstructured":"Gafni, J. et al. Caspase-6 activity in a BACHD mouse modulates steady-state levels of mutant huntingtin protein but is not necessary for production of a 586 amino acid proteolytic fragment. J. Neurosci. 32, 7454\u20137465 (2012).","journal-title":"J. Neurosci."},{"key":"1747_CR74","doi-asserted-by":"publisher","first-page":"E7977","DOI":"10.1073\/pnas.1704640114","volume":"114","author":"KB Dagbay","year":"2017","unstructured":"Dagbay, K. B. & Hardy, J. A. Multiple proteolytic events in caspase-6 self-activation impact conformations of discrete structural regions. Proc. Natl Acad. Sci. USA 114, E7977\u2013E7986 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1747_CR75","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.cell.2020.03.040","volume":"181","author":"M Zheng","year":"2020","unstructured":"Zheng, M., Karki, R., Vogel, P. & Kanneganti, T. D. Caspase-6 is a key regulator of innate immunity, inflammasome activation, and host defense. Cell 181, 674\u2013687.e13 (2020).","journal-title":"Cell"},{"key":"1747_CR76","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1146\/annurev-pharmtox-010814-124414","volume":"55","author":"XJ Wang","year":"2015","unstructured":"Wang, X. J., Cao, Q., Zhang, Y. & Su, X. D. Activation and regulation of caspase-6 and its role in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 55, 553\u2013572 (2015).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"1747_CR77","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1600-6143.2006.01595.x","volume":"7","author":"E Baskin-Bey","year":"2007","unstructured":"Baskin-Bey, E. et al. Clinical trial of the pan-caspase inhibitor, IDN-6556, in human liver preservation injury. Am. J. Transplant. 7, 218\u2013225 (2007).","journal-title":"Am. J. Transplant."},{"key":"1747_CR78","first-page":"68","volume":"13","author":"SH MacKenzie","year":"2010","unstructured":"MacKenzie, S. H., Schipper, J. L. & Clark, A. C. The potential for caspases in drug discovery. Curr. Opin. Drug Discov. Dev. 13, 68\u201376 (2010).","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"1747_CR79","doi-asserted-by":"publisher","first-page":"e154108","DOI":"10.1172\/jci.insight.154108","volume":"7","author":"H Kim","year":"2022","unstructured":"Kim, H. et al. A pathogenic proteolysis-resistant huntingtin isoform induced by an antisense oligonucleotide maintains huntingtin function. JCI Insight 7, e154108 (2022).","journal-title":"JCI Insight"},{"key":"1747_CR80","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/ng0298-150","volume":"18","author":"D Martindale","year":"1998","unstructured":"Martindale, D. et al. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nat. Genet. 18, 150\u2013154 (1998).","journal-title":"Nat. Genet."},{"key":"1747_CR81","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","volume":"23","author":"JG Hodgson","year":"1999","unstructured":"Hodgson, J. G. et al. A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23, 181\u2013192 (1999).","journal-title":"Neuron"},{"key":"1747_CR82","doi-asserted-by":"publisher","first-page":"712555","DOI":"10.3389\/fneur.2021.712555","volume":"12","author":"KM Kinnunen","year":"2021","unstructured":"Kinnunen, K. M. et al. Volumetric MRI-based biomarkers in Huntington\u2019s disease: an evidentiary review. Front. Neurol. 12, 712555 (2021).","journal-title":"Front. Neurol."},{"key":"1747_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1755-5949.2008.00068.x","volume":"15","author":"F Squitieri","year":"2009","unstructured":"Squitieri, F. et al. Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington\u2019s disease. CNS Neurosci. Ther. 15, 1\u201311 (2009).","journal-title":"CNS Neurosci. Ther."},{"key":"1747_CR84","first-page":"3678","volume":"126","author":"M Costanzo","year":"2013","unstructured":"Costanzo, M. et al. Transfer of polyglutamine aggregates in neuronal cells occurs in tunneling nanotubes. J. Cell Sci. 126, 3678\u20133685 (2013).","journal-title":"J. Cell Sci."},{"key":"1747_CR85","doi-asserted-by":"publisher","first-page":"9000","DOI":"10.1523\/JNEUROSCI.0118-17.2017","volume":"37","author":"K Trajkovic","year":"2017","unstructured":"Trajkovic, K., Jeong, H. & Krainc, D. Mutant huntingtin is secreted via a late endosomal\/lysosomal unconventional secretory pathway. J. Neurosci. 37, 9000\u20139012 (2017).","journal-title":"J. Neurosci."},{"key":"1747_CR86","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ng1095-155","volume":"11","author":"S Zeitlin","year":"1995","unstructured":"Zeitlin, S., Liu, J.-P., Chapman, D. L., Papaioannou, V. E. & Efstratiadis, A. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington\u2019s disease gene homologue. Nat. Genet. 11, 155\u2013163 (1995).","journal-title":"Nat. Genet."},{"key":"1747_CR87","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1021\/acs.biochem.9b00573","volume":"58","author":"S Park","year":"2019","unstructured":"Park, S. & Beal, P. A. Off-target editing by CRISPR-guided DNA base editors. Biochemistry 58, 3727\u20133734 (2019).","journal-title":"Biochemistry"},{"key":"1747_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16117-8","volume":"11","author":"P Chatterjee","year":"2020","unstructured":"Chatterjee, P. et al. A Cas9 with PAM recognition for adenine dinucleotides. Nat. Commun. 11, 2474 (2020).","journal-title":"Nat. Commun."},{"key":"1747_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41829-y","volume":"14","author":"L Zhao","year":"2023","unstructured":"Zhao, L. et al. PAM-flexible genome editing with an engineered chimeric Cas9. Nat. Commun. 14, 6175 (2023).","journal-title":"Nat. Commun."},{"key":"1747_CR90","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41587-022-01533-6","volume":"41","author":"ME Neugebauer","year":"2022","unstructured":"Neugebauer, M. E. et al. Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity. Nat. Biotechnol. 41, 673\u2013685 (2022).","journal-title":"Nat. Biotechnol."},{"key":"1747_CR91","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41587-022-01611-9","volume":"41","author":"DK Lam","year":"2023","unstructured":"Lam, D. K. et al. Improved cytosine base editors generated from TadA variants. Nat. Biotechnol. 41, 686\u2013697 (2023).","journal-title":"Nat. Biotechnol."},{"key":"1747_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45969-7","volume":"15","author":"E Zhang","year":"2024","unstructured":"Zhang, E. et al. Phage-assisted evolution of highly active cytosine base editors with enhanced selectivity and minimal sequence context preference. Nat. Commun. 15, 1697 (2024).","journal-title":"Nat. Commun."},{"key":"1747_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07988-z","volume":"10","author":"P Liang","year":"2019","unstructured":"Liang, P. et al. Genome-wide profiling of adenine base editor specificity by EndoV-seq. Nat. Commun. 10, 67 (2019).","journal-title":"Nat. Commun."},{"key":"1747_CR94","doi-asserted-by":"crossref","unstructured":"Southwell, A. L. et al. A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin alleles. Hum. Mol. Genet. 26, 1115\u20131132 (2017).","DOI":"10.1093\/hmg\/ddx021"},{"key":"1747_CR95","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.drudis.2014.03.016","volume":"19","author":"A Kumar","year":"2014","unstructured":"Kumar, A., Vaish, M. & Ratan, R. R. Transcriptional dysregulation in Huntington\u2019s disease: a failure of adaptive transcriptional homeostasis. Drug Discov. Today 19, 956\u2013962 (2014).","journal-title":"Drug Discov. Today"},{"key":"1747_CR96","doi-asserted-by":"crossref","unstructured":"Malla, B., Guo, X., Senger, G., Chasapopoulou, Z. & Yildirim, F. A systematic review of transcriptional dysregulation in Huntington\u2019s disease studied by RNA sequencing. Front. Genet. 12, 751033 (2021).","DOI":"10.3389\/fgene.2021.751033"},{"key":"1747_CR97","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nbt.3803","volume":"35","author":"YB Kim","year":"2017","unstructured":"Kim, Y. B. et al. Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions. Nat. Biotechnol. 35, 371\u2013376 (2017).","journal-title":"Nat. Biotechnol."},{"key":"1747_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54529-y","volume":"15","author":"A Miskalis","year":"2024","unstructured":"Miskalis, A. et al. SPLICER: a highly efficient base editing toolbox that enables in vivo therapeutic exon skipping. Nat. Commun. 15, 10354 (2024).","journal-title":"Nat. Commun."},{"key":"1747_CR99","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-1-4939-7795-6_13","volume":"1772","author":"M Gapinske","year":"2018","unstructured":"Gapinske, M., Tague, N., Winter, J., Underhill, G. H. & Perez-Pinera, P. Targeted gene knock out using nuclease-assisted vector integration: hemi- and homozygous deletion of JAG1. Methods Mol. Biol. 1772, 233\u2013248 (2018).","journal-title":"Methods Mol. Biol."},{"key":"1747_CR100","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/crispr.2018.0014","volume":"1","author":"MG Kluesner","year":"2018","unstructured":"Kluesner, M. G. et al. EditR: a method to quantify base editing from Sanger sequencing. CRISPR J. 1, 239\u2013250 (2018).","journal-title":"CRISPR J."},{"key":"1747_CR101","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the $${2}^{-\\varDelta \\varDelta {C}_{{\\rm{T}}}}$$ Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"1747_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law, C. W. et al. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).","journal-title":"Genome Biol."},{"key":"1747_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtm.2018.05.001","volume":"10","author":"SM Crosson","year":"2018","unstructured":"Crosson, S. M., Dib, P., Kennon Smith, J. & Zolotukhin, S. Helper-free production of laboratory grade AAV and purification by iodixanol density gradient centrifugation. Mol. Ther. Methods Clin. Dev. 10, 1\u20137 (2018).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1747_CR104","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","volume":"30","author":"A Fedorov","year":"2012","unstructured":"Fedorov, A. et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn. Reson. Imaging 30, 1323\u20131341 (2012).","journal-title":"Magn. Reson. Imaging"},{"key":"1747_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-7-80","volume":"7","author":"JM Van Raamsdonk","year":"2006","unstructured":"Van Raamsdonk, J. M., Pearson, J., Murphy, Z., Hayden, M. R. & Leavitt, B. R. Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease. BMC Neurosci. 7, 80 (2006).","journal-title":"BMC Neurosci."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01747-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01747-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01747-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T09:02:24Z","timestamp":1785315744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01747-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":105,"alternative-id":["1747"],"URL":"https:\/\/doi.org\/10.1038\/s41551-026-01747-y","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have filed patent applications on CRISPR technologies (US12612612B2, United States, Published 04-28-2026 US Application No.: 19\/387,082, United States, Filed November 12, 2025).","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}